MPS Pharmaa Limited (BOM:531686)
1.680
-0.080 (-4.55%)
At close: Jan 12, 2026
MPS Pharmaa Market Cap
MPS Pharmaa has a market cap or net worth of 32.11 million as of January 23, 2026. Its market cap has increased by 380.00% in one year.
Market Cap
32.11M
Enterprise Value
107.12M
Revenue
437.20K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.68
Market Cap Chart
Since January 18, 2005, MPS Pharmaa's market cap has decreased from 108.87M to 32.11M, a decrease of -70.51%. That is a compound annual growth rate of -5.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 32.11M | -9.19% |
| Dec 29, 2025 | 35.36M | -56.06% |
| Dec 30, 2024 | 80.46M | 50.90% |
| Dec 26, 2023 | 53.32M | 46.07% |
| Dec 14, 2022 | 36.50M | 50.39% |
| Dec 27, 2021 | 24.27M | 243.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Colinz Laboratories | 121.02M |
| Beryl Drugs | 112.85M |
| Ortin Global | 105.79M |
| Shamrock Industrial Company | 105.25M |
| Unjha Formulations | 96.42M |
| Vivanza Biosciences | 84.00M |
| Ganga Pharmaceuticals | 82.58M |
| Decipher Labs | 79.29M |